University of Texas Medical Center at Houston, Houston, TX.
Medical College of Wisconsin, Milwaukee, WI.
J Am Coll Surg. 2021 Jun;232(6):1007-1016.e5. doi: 10.1016/j.jamcollsurg.2021.02.016. Epub 2021 Mar 22.
Delayed intracranial hemorrhage (ICH) after a negative initial head cat scan (CT) is a recognized complication after blunt trauma but the risk of this condition is unknown. Due to theoretical increased risk in patients on direct oral anticoagulants (DOACs) and inability to monitor degree of anticoagulation, there is a lack of consensus regarding need for additional observation or routine repeat head CT. We hypothesized that patients on DOACs would have a low risk of delayed ICH after blunt head trauma.
In June 2020, an electronic literature search of MEDLINE (Ovid), Embase (Elsevier), and Cochrane Library was performed by a medical librarian (TH) using a combination of keywords and subject headings. Databases were searched from inception through June 2020. Included studies reported outcome data on trauma patients greater than 18 years old who were taking anticoagulants and were observed after initial normal head CT. A meta-analysis was performed using a random effects model. The Newcastle-Ottawa Scale (NOS) was utilized for assessing the quality of nonrandomized studies in meta-analyses.
Our electronic search returned 5719 papers and after removal of duplications, 72 underwent full review, and 12 met final inclusion/exclusion criteria. Four thousand eight hundred ninety one of 5289 (92%) patients suffered a ground level fall. Four studies reported routine repeat CT scans on all patients while the remaining only repeated CT scans for symptoms. Overall, 5289 patients were studied and 1263 (23.9%) were on a DOAC. Sixty-nine patients suffered delayed intracranial hemorrhage, 25 on DOAC and 44 on warfarin. The pooled weighted proportion for delayed ICH on DOAC was 2.43% (95% CI, 1.31 – 3.88%) compared to 2.31% (95% CI, 1.26 – 3.66%) on warfarin. Eighty six percent of patients (59/69) who suffered delayed ICH had no clinical consequences while 0.16% (2/1263) of those on DOAC and 0.48% (8/1788) of those on warfarin died from complications following delayed ICH. The overall crude risk of death from delayed ICH while on DOAC or Warfarin was 0.36% (11/3051).
The risk of delayed ICH following low energy blunt head trauma for patients on DOACs is low, and the risk of a clinically significant bleed is even lower. The practice of routinely observing or systematically repeating head CT in patients on DOACs after low energy blunt head trauma with initially negative head CT may not be warranted.
在初次头部 CT 扫描(CT)阴性后出现迟发性颅内出血(ICH)是钝性创伤后一种公认的并发症,但这种情况的风险尚不清楚。由于直接口服抗凝剂(DOAC)患者的理论风险增加,并且无法监测抗凝程度,因此对于是否需要额外观察或常规重复头部 CT,尚无共识。我们假设 DOAC 患者在钝性头部创伤后发生迟发性 ICH 的风险较低。
2020 年 6 月,一名医学图书馆员(TH)通过组合使用关键词和主题词,对 MEDLINE(Ovid)、Embase(Elsevier)和 Cochrane 图书馆进行了电子文献检索。数据库从建立到 2020 年 6 月进行了搜索。纳入的研究报告了大于 18 岁且正在服用抗凝药物并在初次正常头部 CT 后接受观察的创伤患者的结局数据。使用随机效应模型进行了荟萃分析。使用纽卡斯尔-渥太华量表(NOS)评估荟萃分析中非随机研究的质量。
我们的电子搜索共返回 5719 篇论文,经去重后,有 72 篇进行了全面审查,最终有 12 篇符合最终的纳入/排除标准。4891 例患者中有 4891 例(92%)从平地坠落。四项研究报告所有患者常规重复 CT 扫描,其余研究仅对有症状者重复 CT 扫描。总的来说,5289 例患者接受了研究,其中 1263 例(23.9%)服用 DOAC。69 例发生迟发性颅内出血,25 例服用 DOAC,44 例服用华法林。服用 DOAC 的患者迟发性 ICH 的加权总体比例为 2.43%(95%CI,1.31-3.88%),而服用华法林的患者为 2.31%(95%CI,1.26-3.66%)。迟发性 ICH 后 86%(59/69)的患者没有临床后果,而服用 DOAC 的患者中有 0.16%(2/1263)和服用华法林的患者中有 0.48%(8/1788)因迟发性 ICH 并发症死亡。在服用 DOAC 或华法林的患者中,迟发性 ICH 导致死亡的总体粗风险为 0.36%(11/3051)。
在 DOAC 患者中,低能量钝性头部创伤后迟发性 ICH 的风险较低,而具有临床意义的出血风险则更低。在低能量钝性头部创伤后,对于初次头部 CT 阴性且持续服用 DOAC 的患者,常规观察或系统重复头部 CT 的做法可能没有必要。